These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33093036)

  • 1. Development and internal validation of prognostic models to predict negative health outcomes in older patients with multimorbidity and polypharmacy in general practice.
    Müller BS; Uhlmann L; Ihle P; Stock C; von Buedingen F; Beyer M; Gerlach FM; Perera R; Valderas JM; Glasziou P; van den Akker M; Muth C
    BMJ Open; 2020 Oct; 10(10):e039747. PubMed ID: 33093036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a complex intervention on Prioritising Multimedication in Multimorbidity (PRIMUM) in primary care: results of a pragmatic cluster randomised controlled trial.
    Muth C; Uhlmann L; Haefeli WE; Rochon J; van den Akker M; Perera R; Güthlin C; Beyer M; Oswald F; Valderas JM; Knottnerus JA; Gerlach FM; Harder S
    BMJ Open; 2018 Feb; 8(2):e017740. PubMed ID: 29478012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
    Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
    Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic model predicted deterioration in health-related quality of life in older patients with multimorbidity and polypharmacy.
    González-González AI; Meid AD; Dinh TS; Blom JW; van den Akker M; Elders PJM; Thiem U; De Gaudry DK; Swart KMA; Rudolf H; Bosch-Lenders D; Trampisch HJ; Meerpohl JJ; Gerlach FM; Flaig B; Kom G; Snell KIE; Perera R; Haefeli WE; Glasziou PP; Muth C
    J Clin Epidemiol; 2021 Feb; 130():1-12. PubMed ID: 33065164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in residents aged 18 years and older with and without disease: findings from the First Provincial Health Services Survey of Hunan, China.
    Deng X; Dong P; Zhang L; Tian D; Zhang L; Zhang W; Li L; Deng J; Ning P; Hu G
    BMJ Open; 2017 Sep; 7(9):e015880. PubMed ID: 28871016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are Anticholinergic Symptoms a Risk Factor for Falls in Older General Practice Patients With Polypharmacy? Study Protocol for the Development and Validation of a Prognostic Model.
    Dinh TS; González-González AI; Meid AD; Snell KIE; Rudolf H; Brueckle MS; Blom JW; Thiem U; Trampisch HJ; Elders PJM; Donner-Banzhoff N; Gerlach FM; Harder S; van den Akker M; Glasziou PP; Haefeli WE; Muth C
    Front Pharmacol; 2020; 11():577747. PubMed ID: 33519441
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-study).
    Verdoorn S; Kwint HF; Blom JW; Gussekloo J; Bouvy ML
    PLoS Med; 2019 May; 16(5):e1002798. PubMed ID: 31067214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study to test the feasibility of a trial design and complex intervention on PRIoritising MUltimedication in Multimorbidity in general practices (PRIMUMpilot).
    Muth C; Harder S; Uhlmann L; Rochon J; Fullerton B; Güthlin C; Erler A; Beyer M; van den Akker M; Perera R; Knottnerus A; Valderas JM; Gerlach FM; Haefeli WE
    BMJ Open; 2016 Jul; 6(7):e011613. PubMed ID: 27456328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project).
    Prados-Torres A; Del Cura-González I; Prados-Torres D; López-Rodríguez JA; Leiva-Fernández F; Calderón-Larrañaga A; López-Verde F; Gimeno-Feliu LA; Escortell-Mayor E; Pico-Soler V; Sanz-Cuesta T; Bujalance-Zafra MJ; Morey-Montalvo M; Boxó-Cifuentes JR; Poblador-Plou B; Fernández-Arquero JM; González-Rubio F; Ramiro-González MD; Coscollar-Santaliestra C; Martín-Fernández J; Barnestein-Fonseca MP; Valderas-Martínez JM; Marengoni A; Muth C;
    Implement Sci; 2017 Apr; 12(1):54. PubMed ID: 28449721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of falls and hospital admissions in people with cognitive impairment in day-care: role of multimorbidity, polypharmacy, and potentially inappropriate medication.
    Scheel J; Luttenberger K; Graessel E; Kratzer A; Donath C
    BMC Geriatr; 2022 Aug; 22(1):682. PubMed ID: 35982409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of general practice-based pharmacists' services to optimize medicines management in older people with multimorbidity and polypharmacy.
    Hasan Ibrahim AS; Barry HE; Hughes CM
    Fam Pract; 2021 Jul; 38(4):509-523. PubMed ID: 33506870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the MULTIPAP Plus intervention in youngest-old patients with multimorbidity and polypharmacy aimed at improving prescribing practices in primary care: study protocol of a cluster randomized trial.
    Del Cura-González I; López-Rodríguez JA; Leiva-Fernández F; Gimeno-Feliu LA; Pico-Soler V; Bujalance-Zafra MJ; Domínguez-Santaella M; Polentinos-Castro E; Poblador-Plou B; Ara-Bardají P; Aza-Pascual-Salcedo M; Rogero-Blanco M; Castillo-Jiménez M; Lozano-Hernández C; Gimeno-Miguel A; González-Rubio F; Medina-García R; González-Hevilla A; Gil-Conesa M; Martín-Fernández J; Valderas JM; Marengoni A; Muth C; Prados-Torres JD; Prados-Torres A;
    Trials; 2022 Jun; 23(1):479. PubMed ID: 35681224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study.
    Lopez-Rodriguez JA; Rogero-Blanco E; Aza-Pascual-Salcedo M; Lopez-Verde F; Pico-Soler V; Leiva-Fernandez F; Prados-Torres JD; Prados-Torres A; Cura-González I;
    PLoS One; 2020; 15(8):e0237186. PubMed ID: 32785232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice.
    von Buedingen F; Hammer MS; Meid AD; Müller WE; Gerlach FM; Muth C
    BMC Fam Pract; 2018 Jul; 19(1):131. PubMed ID: 30055583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social support, social context and nonadherence to treatment in young senior patients with multimorbidity and polypharmacy followed-up in primary care. MULTIPAP Study.
    Lozano-Hernández CM; López-Rodríguez JA; Leiva-Fernández F; Calderón-Larrañaga A; Barrio-Cortes J; Gimeno-Feliu LA; Poblador-Plou B; Cura-González ID;
    PLoS One; 2020; 15(6):e0235148. PubMed ID: 32579616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of ambulatory geriatric rehabilitation on polypharmacy and potentially inappropriate medication-an observational study].
    Kiel S; Zimak C; Schmidt CO; Chenot JF
    Z Gerontol Geriatr; 2020 Aug; 53(5):416-422. PubMed ID: 31392420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trial.
    Jungo KT; Ansorg AK; Floriani C; Rozsnyai Z; Schwab N; Meier R; Valeri F; Stalder O; Limacher A; Schneider C; Bagattini M; Trelle S; Spruit M; Schwenkglenks M; Rodondi N; Streit S
    BMJ; 2023 May; 381():e074054. PubMed ID: 37225248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the management of multimorbidity in general practice: protocol of a cluster randomised controlled trial (The 3D Study).
    Man MS; Chaplin K; Mann C; Bower P; Brookes S; Fitzpatrick B; Guthrie B; Shaw A; Hollinghurst S; Mercer S; Rafi I; Thorn J; Salisbury C
    BMJ Open; 2016 Apr; 6(4):e011261. PubMed ID: 27113241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-Related Quality of Life and Health Service Use among Multimorbid Middle-Aged and Older-Aged Adults in China: A Cross-Sectional Study in Shandong Province.
    Zhao Q; Wang J; Nicholas S; Maitland E; Sun J; Jiao C; Xu L; Leng A
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33322307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.
    McCarthy C; Clyne B; Corrigan D; Boland F; Wallace E; Moriarty F; Fahey T; Hughes C; Gillespie P; Smith SM
    Implement Sci; 2017 Aug; 12(1):99. PubMed ID: 28764753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.